Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZELBORAF for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 109 adverse event reports in the FDA FAERS database where ZELBORAF was used for Malignant melanoma.

Most Reported Side Effects for ZELBORAF

Side Effect Reports % Deaths Hosp.
Disease progression 62 17.3% 29 4
Death 49 13.7% 49 4
Rash 45 12.6% 4 10
Arthralgia 29 8.1% 2 9
Fatigue 17 4.8% 3 8
Nausea 16 4.5% 3 10
Asthenia 14 3.9% 2 4
Dysphagia 14 3.9% 1 4
Erythema 14 3.9% 4 2
Photosensitivity reaction 14 3.9% 3 4
Pyrexia 13 3.6% 1 6
Diarrhoea 12 3.4% 4 6
Pain in extremity 12 3.4% 1 5
Drug ineffective 11 3.1% 6 3
Malignant neoplasm progression 11 3.1% 7 2

Other Indications for ZELBORAF

Metastatic malignant melanoma (130) Product used for unknown indication (90) Neoplasm malignant (22)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) TRAMETINIB (1,448) COBIMETINIB (1,324)

Related Pages

ZELBORAF Full Profile All Malignant melanoma Drugs ZELBORAF Demographics ZELBORAF Timeline